CBER's Dozen: Novel Biologics Approved In 2015
An interactive chart listing the novel biologics cleared by FDA's Center for Biologics Evaluation and Research in 2015.
You may also be interested in...
Rigorous planning and a multidisciplinary team including database experts and healthcare specialists with local knowledge are vital to effective real-world evidence, white paper shows.
The latest submission and expedited review program news and highlights from our US FDA Performance Tracker.
The latest news about products accepted into US FDA expedited review programs.